The National Institute on Drug Abuse (NIDA) has just alerted the research community that populations with Substance Use Disorders may be more susceptible to coronavirus. On Monday, the Substance Abuse and Mental Health Services Administration (SAMHSA) posted COVID-19 guidance providing potential flexibility for opioid treatment programs.
![](https://www.cadca.org/wp-content/uploads/2022/03/user-noimage.jpg)